Patents by Inventor Alan L. Kriz

Alan L. Kriz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7803927
    Abstract: Methods and compositions for the expression of transgenes in monocot plants including maize are disclosed. In the invention, gene silencing is avoided by use of monocot-homeologous sequences from plants of the genus Coix for transformation. Included in these transgene sequences are Coix promoters, enhancers, coding sequences and terminators. Suitable alternatives to maize-derived transgenes are desirable for expression in maize in that homology-based gene silencing can limit or effectively eliminate transgene expression.
    Type: Grant
    Filed: August 14, 2007
    Date of Patent: September 28, 2010
    Assignee: Monsanto Technology LLC
    Inventors: Alan L. Kriz, Michael H. Luethy, Dale A. Voyles
  • Patent number: 7803928
    Abstract: Methods and compositions for the expression of transgenes in monocot plants including maize are disclosed. In the invention, gene silencing is avoided by use of monocot-homeologous sequences from plants of the genus Coix for transformation. Included in these transgene sequences are Coix promoters, enhancers, coding sequences and terminators. Suitable alternatives to maize-derived transgenes are desirable for expression in maize in that homology-based gene silencing can limit or effectively eliminate transgene expression.
    Type: Grant
    Filed: August 14, 2007
    Date of Patent: September 28, 2010
    Assignee: Monsanto Technology LLC
    Inventors: Alan L. Kriz, Michael H. Luethy, Dale A. Voyles
  • Patent number: 7741538
    Abstract: Methods and compositions for the expression of transgenes in monocot plants including maize are disclosed. In the invention, gene silencing is avoided by use of monocot-homeologous sequences from plants of the genus Coix for transformation. Included in these transgene sequences are Coix promoters, enhancers, coding sequences and terminators. Suitable alternatives to maize-derived transgenes are desirable for expression in maize in that homology-based gene silencing can limit or effectively eliminate transgene expression.
    Type: Grant
    Filed: August 14, 2007
    Date of Patent: June 22, 2010
    Assignee: Dekalb Genetics Corporation
    Inventors: Alan L. Kriz, Michael H. Luethy, Dale A. Voyles
  • Patent number: 7683237
    Abstract: The present invention provides a transgenic maize plant having in its genome transgenic DNA including sequence for zein reduction and sequence for lysine biosynthesis, whereby expression of the transgenic DNA results in a synergistically increased lysine content of seed of the transgenic maize plant. The invention further provides a method for providing maize seed with synergistically increased lysine content.
    Type: Grant
    Filed: March 10, 2005
    Date of Patent: March 23, 2010
    Assignee: Monsanto Technology LLC
    Inventors: Alan L. Kriz, Shihshieh Huang, Michael H. Luethy
  • Publication number: 20090199307
    Abstract: Methods and compositions for the expression of transgenes in monocot plants including maize are disclosed. In the invention, gene silencing is avoided by use of monocot-homeologous sequences from plants of the genus Coix for transformation. Included in these transgene sequences are Coix promoters, enhancers, coding sequences and terminators. Suitable alternatives to maize-derived transgenes are desirable for expression in maize in that homology-based gene silencing can limit or effectively eliminate transgene expression.
    Type: Application
    Filed: August 14, 2007
    Publication date: August 6, 2009
    Inventors: Alan L. Kriz, Michael H. Luethy, Dale A. Voyles
  • Publication number: 20090013423
    Abstract: Methods and compositions for the expression of transgenes in monocot plants including maize are disclosed. In the invention, gene silencing is avoided by use of monocot-homeologous sequences from plants of the genus Coix for transformation. Included in these transgene sequences are Coix promoters, enhancers, coding sequences and terminators. Suitable alternatives to maize-derived transgenes are desirable for expression in maize in that homology-based gene silencing can limit or effectively eliminate transgene expression.
    Type: Application
    Filed: August 14, 2007
    Publication date: January 8, 2009
    Inventors: Alan L. Kriz, Michael H. Luethy, Dale A. Voyles
  • Publication number: 20080271212
    Abstract: Methods and compositions for the expression of transgenes in monocot plants including maize are disclosed. In the invention, gene silencing is avoided by use of monocot-homeologous sequences from plants of the genus Coix for transformation. Included in these transgene sequences are Coix promoters, enhancers, coding sequences and terminators. Suitable alternatives to maize-derived transgenes are desirable for expression in maize in that homology-based gene silencing can limit or effectively eliminate transgene expression.
    Type: Application
    Filed: August 14, 2007
    Publication date: October 30, 2008
    Inventors: Alan L. Kriz, Michael H. Luethy, Dale A. Voyles
  • Patent number: 7288403
    Abstract: The present invention provides a method for conferring tolerance to an amino acid analog of tryptophan to a plant and/or altering the tryptophan content of a plant by introducing and expressing an isolated DNA segment encoding an anthranilate synthase in the cells of the plant. Transgenic plants transformed with an isolated DNA segment encoding an anthranilate synthase, as well as seeds and progeny derived from these plants, are also provided. The present invention also provides a cDNA sequence of an alpha and a beta subunit of a maize anthranilate synthase.
    Type: Grant
    Filed: August 3, 2005
    Date of Patent: October 30, 2007
    Inventors: Paul C. Anderson, Paul S. Chomet, Matthew C. Griffor, Alan L. Kriz
  • Patent number: 7256283
    Abstract: The invention provides isolated gamma coixin promoters useful for the expression of heterologous coding sequences in transgenic plants. Further provided by the invention are transgenic plants comprising such promoters, expression constructs for the introduction of heterologous coding sequences into plants, and methods of using the plants and nucleic acids provided by the invention.
    Type: Grant
    Filed: September 11, 2003
    Date of Patent: August 14, 2007
    Assignee: Dekalb Genetics Corporation
    Inventors: Alan L. Kriz, Michael H. Luethy, Dale A. Voyles
  • Patent number: 7078234
    Abstract: This invention provides an embryo specific promoter, e.g. derived from the 5? regulatory region of an emb5 gene. Compositions comprising this promoter include DNA constructs useful for plant transformation and plants transformed with such DNA constructs. Further provided are methods for the expression of transgenes in plants using the embryo specific promoter sequences. The methods of the invention include the direct creation of transgenic plants with the emb5 promoter by genetic transformation, as well as by plant breeding methods. The sequences of the invention represent a valuable new tool for the creation of transgenic plants, preferably having one or more added beneficial characteristics.
    Type: Grant
    Filed: December 10, 2003
    Date of Patent: July 18, 2006
    Assignee: Monsanto Technology LLC
    Inventors: Alan L. Kriz, Dale A. Voyles
  • Publication number: 20040163144
    Abstract: This invention provides an embryo specific promoter, e.g. derived from the 5′ regulatory region of an emb5 gene. Compositions comprising this promoter include DNA constructs useful for plant transformation and plants transformed with such DNA constructs. Further provided are methods for the expression of transgenes in plants using the embryo specific promoter sequences. The methods of the invention include the direct creation of transgenic plants with the emb5 promoter by genetic transformation, as well as by plant breeding methods. The sequences of the invention represent a valuable new tool for the creation of transgenic plants, preferably having one or more added beneficial characteristics.
    Type: Application
    Filed: December 10, 2003
    Publication date: August 19, 2004
    Inventors: Alan L. Kriz, Dale Voyles
  • Patent number: 6635806
    Abstract: Methods and compositions for the expression of transgenes in monocot plants including maize are disclosed. In the invention, gene silencing is avoided by use of monocot-homeologous sequences from plants of the genus Coix for transformation. Included in these transgene sequences are Coix promoters, enhancers, coding sequences and terminators. Suitable alternatives to maize-derived transgenes are desirable for expression in maize in that homology-based gene silencing can limit or effectively eliminate transgene expression.
    Type: Grant
    Filed: May 14, 1998
    Date of Patent: October 21, 2003
    Assignee: DeKalb Genetics Corporation
    Inventors: Alan L. Kriz, Michael H. Luethy, Dale A. Voyles
  • Publication number: 20030167514
    Abstract: The present invention provides a method for conferring tolerance to an amino acid analog of tryptophan to a plant and/or altering the tryptophan content of a plant by introducing and expressing an isolated DNA segment encoding an anthranilate synthase in the cells of the plant. Transgenic plants transformed with an isolated DNA segment encoding an anthranilate synthase, as well as seeds and progeny derived from these plants, are also provided. The present invention also provides a cDNA sequence of an alpha and a beta subunit of a maize anthranilate synthase.
    Type: Application
    Filed: January 29, 2003
    Publication date: September 4, 2003
    Inventors: Paul C. Anderson, Paul S. Chomet, Matthew C. Griffor, Alan L. Kriz
  • Patent number: 6583338
    Abstract: The current invention provides the maize A3 promoter and actin 2 intron. Compositions comprising these sequences are described, as well as transformation constructs derived therefrom. Further provided are methods for the expression of transgenes in plants comprising the use of these sequences. The methods of the invention include the direct creation of transgenic plants with the A3 promoter directly by genetic transformation, as well as by plant breeding methods. The sequences of the invention represent a valuable new tool for the creation of transgenic plants, preferably having one or more added beneficial characteristics.
    Type: Grant
    Filed: May 7, 2001
    Date of Patent: June 24, 2003
    Assignee: DeKalb Genetics Corporation
    Inventors: David McElroy, Alan L. Kriz, Emil M. Orozco, Jr., Matt Griffor
  • Patent number: 6515201
    Abstract: The present invention provides a method for conferring tolerance to an amino acid analog of tryptophan to a plant and/or altering the tryptophan content of a plant by introducing and expressing an isolated DNA segment encoding an anthranilate synthase in the cells of the plant. Transgenic plants transformed with an isolated DNA segment encoding an anthranilate synthase, as well as seeds and progeny derived from these plants, are also provided. The present invention also provides a cDNA sequence of an alpha and a beta subunit of a maize anthranilate synthase.
    Type: Grant
    Filed: December 8, 2000
    Date of Patent: February 4, 2003
    Assignee: DeKalb Genetics Corporation
    Inventors: Paul C. Anderson, Paul S. Chomet, Matthew C. Griffor, Alan L. Kriz
  • Patent number: 6433252
    Abstract: The present invention provides methods and compositions for the identification of transgenic seeds. This is accomplished by use of screenable markers linked to aleurone-specific promoters. The screenable markers can be provided as gene fusions with selectable markers, allowing both selection and screening of transformants. The use of aleurone-specific promoters, which also direct expression in embryogenic tissues, allows efficient selection of transgenic cells and the screening of viable transgenic seeds, while avoiding the deleterious effects associated with constitutive expression of screenable marker genes. Screening of transgenic seeds avoids the need for growing and assaying of seeds for transgenes and allows implementation of automated seed screening techniques for the identification of transgenic seeds.
    Type: Grant
    Filed: October 24, 2000
    Date of Patent: August 13, 2002
    Assignee: Dekalb Genetics Corporation
    Inventors: Alan L. Kriz, Mathew Griffor
  • Publication number: 20020104121
    Abstract: The current invention provides the maize A3 promoter and actin 2 intron. Compositions comprising these sequences are described, as well as transformation constructs derived therefrom. Further provided are methods for the expression of transgenes in plants comprising the use of these sequences. The methods of the invention include the direct creation of transgenic plants with the A3 promoter directly by genetic transformation, as well as by plant breeding methods. The sequences of the invention represent a valuable new tool for the creation of transgenic plants, preferably having one or more added beneficial characteristics.
    Type: Application
    Filed: May 7, 2001
    Publication date: August 1, 2002
    Applicant: DEKALB GENETICS CORPORATION
    Inventors: David McElroy, Alan L. Kriz, Emil M. Orozco, Matt Griffor
  • Publication number: 20020061570
    Abstract: The present invention provides a method for conferring tolerance to an amino acid analog of tryptophan to a plant and/or altering the tryptophan content of a plant by introducing and expressing an isolated DNA segment encoding an anthranilate synthase in the cells of the plant. Transgenic plants transformed with an isolated DNA segment encoding an anthranilate synthase, as well as seeds and progeny derived from these plants, are also provided. The present invention also provides a cDNA sequence of an alpha and a beta subunit of a maize anthranilate synthase.
    Type: Application
    Filed: December 8, 2000
    Publication date: May 23, 2002
    Applicant: DEKALB Genetics Corporation.
    Inventors: Paul C. Anderson, Paul S. Chomet, Matthew C. Griffor, Alan L. Kriz
  • Patent number: 6307123
    Abstract: The present invention provides methods and compositions for the identification of transgenic seeds. This is accomplished by use of screenable markers linked to aleurone-specific promoters. The screenable markers can be provided as gene fusions with selectable markers, allowing both selection and screening of transformants. The use of aleurone-specific promoters, which also direct expression in embryogenic tissues, allows efficient selection of transgenic cells and the screening of viable transgenic seeds, while avoiding the deleterious effects associated with constitutive expression of screenable marker genes. Screening of transgenic seeds avoids the need for growing and assaying of seeds for transgenes and allows implementation of automated seed screening techniques for the identification of transgenic seeds.
    Type: Grant
    Filed: May 18, 1998
    Date of Patent: October 23, 2001
    Assignee: Dekalb Genetics Corporation
    Inventors: Alan L. Kriz, T. Michael Spencer
  • Publication number: 20010029618
    Abstract: The present invention provides a method for conferring tolerance or resistance to water or salt stress in a monocot plant, and/or altering the osmoprotectant content of a monocot plant, by introducing a preselected DNA segment into the plant. This invention also relates to the transformed cells and seeds, and to the fertile plants grown from the transformed cells and to their pollen.
    Type: Application
    Filed: December 7, 2000
    Publication date: October 11, 2001
    Applicant: DEKALB Genetics Corporation.
    Inventors: Paul C. Anderson, Paul S. Chomet, Matthew C. Griffor, Alan L. Kriz